EN
Enzolytics Inc.
ENZC · OTC
$0.00 +66.67% (+$0.00)
1M -16.67%
Market Cap $2.76M
P/E Ratio -
Div. Yield -
ROE 0.33%
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
1 /100
Poor ROIC 0.31%
ROE 0.33%
ROA 0.20%
Debt
53 /100
Moderate Current ratio 0.63x
Int. coverage -9.69x
Net debt/EBITDA -2.97x
Stability
29 /100
Unstable Beta 0.51x
EPS volatility 256.46%
Profitable years 0
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ENZC
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Steven Sharabura
Employees
1
Headquarters
Plano